Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.
Pal SK, Bergerot P, Dizman N, Bergerot C, Adashek J, Madison R, Chung JH, Ali SM, Jones JO, Salgia R.
Pal SK, et al. Among authors: jones jo.
Eur Urol. 2018 Jul;74(1):124-128. doi: 10.1016/j.eururo.2018.03.032.
Eur Urol. 2018.
PMID: 29685646
No abstract available.